Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†

(2014) B. Chauffert et al.   ANNALS OF ONCOLOGY

Quality of life as a predictor of overall survival after breast cancer treatment

(2013) Suzana Sales De Aguiar et al.   QUALITY OF LIFE RESEARCH

Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion

(2011) Walter Stummer et al.   ACTA NEUROCHIRURGICA

Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer?

(2011) Donald P Braun et al.   Health and Quality of Life Outcomes

An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients

(2010) Martin J.B. Taphoorn et al.   EUROPEAN JOURNAL OF CANCER

Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

(2009) Chantal Quinten et al.   LANCET ONCOLOGY

Validation of Patient's Self-Reported Social Functioning As an Independent Prognostic Factor for Survival in Metastatic Colorectal Cancer Patients: Results of an International Study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer

(2008) Fabio Efficace et al.   JOURNAL OF CLINICAL ONCOLOGY